|
g, inhalation-rabbit, �wult TCLo: l g/m3/24H (female 7-20D post) :
<br /> Teratogenic effects ARTODN 8, 425, 85
<br /> 'inhalation-rat TCLo:50 ppm/24H (female 7-14D post) : Teratogenic effects
<br /> JOHYAY 24, 363, 80
<br /> inhalation-rat TCLo:50 ppm/24H (female 7-14D post) : Teratogenic effects
<br /> JOHYAY 24, 363, 80
<br /> subcutaneous-mouse TDLo: 1100 mg/kg (female 12D post) : Teratogenic
<br /> effects TOXID9 1, 125, 81
<br /> inhalation-rabbit, adult TCLo:l g/m3/24H (female 7-20D post) :
<br /> Reproductive effects ARTODN 8, 425, 85
<br /> inhalation-rat TCLo: 670 mg/m3/24H (15D pre/1-22D preg) : Reproductive
<br /> effects HYSAAV 33, 327, 68
<br /> inhalation-rat TCLo:150 ppm/24H (female 7-14D post) : Reproductive
<br /> effects JOHYAY 24, 363, 80
<br /> intraperitoneal-mouse TDLo:5 mg/kg (male 1D pre) : Reproductive effects
<br /> TPKVAL 15, 30, 79
<br /> inhalation-mouse TCLo:5 ppm (female 6-15D post) : Teratogenic effects
<br /> TXCYAC 42, 171, 86
<br /> inhalation-rat TCLo: 150 ppm/24H (female 7-14D post) : Teratogenic effects
<br /> JOHYAY 24,363, 80
<br /> inhalation-rabbit, adult TCLo:l g/m3/24H (female 7-20D post) :
<br /> Teratogenic effects ARTODN 8, 425, 85
<br /> inhalation-man TCLo:200 mg/m3/78W-I: Carcinogenic effects,BLD
<br /> EJCAAH 7, 83, 71
<br /> inhalation-human TCLo:10 ppm/8H/10Y-I: Carcinogenic effects,BLD
<br /> TRBMAV 37, 153, 78
<br /> oral-rat TDLo:52 g/kg/52W-I: Carcinogenic effects MELAAD 70,352, 79
<br /> inhalation-rat TCLo:1200 ppm/6H/lOW-I: Equivocal tumorigenic agent
<br /> PAACA3 25,75, 84
<br /> oral-mouse TDLo: 18250 mg/kg/2Y-C: Carcinogenic effects NTPTR* NTP-TR-
<br /> 289, 86
<br /> inhalation-mouse TCLo:300 ppm/6H/16W-I: Equivocal tumorigenic agent
<br /> TXAPA99 75, 358, 84
<br /> skin-mouse TDLo: 1200 g/kg/49W-I: Neoplastic effects BJCAAI
<br /> 16,275, 62
<br /> intraperitoneal-mouse TDLo:1200 mg/kg/8W-I: Neoplastic effects
<br /> TXAPA99 82, 19, 86
<br /> subcutaneous-mouse TDLo: 600 mg/kg/17W-I: Equivocal tumorigenic agent
<br /> KRANAW 9, 403, 32
<br /> parenteral-mouse TDLo: 670 mg/kg/19W-I: Equivocal tumorigenic agent
<br /> KLWOAZ 12, 109, 33
<br /> inhalation-human TC:150 ppm/15M/8Y-I: Carcinogenic effects,BLD
<br /> BLOOAW 52,285, 78
<br /> oral-rat TD:52 g/kg/lY-I: Carcinogenic effects AJIMD8 4,589, 83
<br /> oral-rat TD:10 g/kg/52W-I: Carcinogenic effects MELAAD 70, 352, 79
<br /> inhalation-man TC: 600 mg/m3/4Y-I: Carcinogenic effects,BLD NEJMAG
<br /> 271, 872, 64
<br /> inhalation-man TC:150 ppm/11Y-I: Carcinogenic effects,BLD BLUTA9
<br /> 28,293, 74
<br /> inhalation-mouse TC:1200 ppm/6H/lOW-I: Equivocal tumorigenic agent
<br /> PAACA3 25, 75, 84
<br /> oral-mouse TD:2400 mg/kg/8W-I : Neoplastic effects TXAPA99 82, 19, 86
<br /> inhalation-human TC:8 ppb/4W-I: Carcinogenic effects,BLD NEJMAG
<br /> 316, 1044, 87
<br /> 8
<br /> Site Safety 6 Health Plan Rev. /1. 0
<br /> October 20, 1997
<br />
|